ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 1 filers reported holding ANAPTYSBIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,744,783 | -11.7% | 431,224 | 0.0% | 0.73% | +3.4% |
| Q2 2023 | $8,771,096 | -6.5% | 431,224 | 0.0% | 0.71% | -8.8% |
| Q1 2023 | $9,383,434 | -29.8% | 431,224 | +0.0% | 0.78% | -31.8% |
| Q4 2022 | $13,357,434 | +21.5% | 431,024 | 0.0% | 1.14% | +31.1% |
| Q3 2022 | $10,995,000 | +25.7% | 431,024 | 0.0% | 0.87% | +13.9% |
| Q2 2022 | $8,750,000 | -17.9% | 431,024 | 0.0% | 0.76% | -7.4% |
| Q1 2022 | $10,664,000 | -29.7% | 431,024 | -1.3% | 0.82% | -15.1% |
| Q4 2021 | $15,172,000 | +28.1% | 436,592 | 0.0% | 0.97% | +35.7% |
| Q3 2021 | $11,840,000 | +4.6% | 436,592 | 0.0% | 0.72% | +14.6% |
| Q2 2021 | $11,321,000 | +20.3% | 436,592 | 0.0% | 0.62% | +16.4% |
| Q1 2021 | $9,409,000 | +5.1% | 436,592 | +4.9% | 0.54% | +14.3% |
| Q4 2020 | $8,950,000 | +64.6% | 416,292 | +12.9% | 0.47% | +56.9% |
| Q3 2020 | $5,439,000 | – | 368,722 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $81,462,731 | 11.84% |
| EcoR1 Capital, LLC | 7,521,024 | $233,076,534 | 7.09% |
| 5AM Venture Management, LLC | 357,733 | $11,086,146 | 2.98% |
| Boxer Capital, LLC | 1,300,000 | $40,287,000 | 2.12% |
| Frazier Life Sciences Management, L.P. | 899,700 | $27,881,703 | 1.73% |
| Palo Alto Investors LP | 431,024 | $13,357,434 | 1.14% |
| Logos Global Management LP | 250,000 | $7,747,500 | 0.91% |
| BRAIDWELL LP | 726,122 | $22,502,521 | 0.75% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,161,826 | $36,004,988 | 0.74% |
| Rock Springs Capital Management LP | 576,600 | $17,868,834 | 0.43% |